These effects, together with a past report demonstrating that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,2 support the strategy of concentrating on ACKR3 as a novel solution to modulate the opioid process, which could open up new therapeutic avenues for opioid-similar Diseases. (two) The health practitioner https://richardp739nfv5.blogvivi.com/profile